Comparative Analysis of AI Tools for Disseminating ADA 2025 Diabetes Care Standards: Implications for Cardiovascular Physicians
Journal of Diabetes,
Journal Year:
2025,
Volume and Issue:
17(3)
Published: March 1, 2025
Language: Английский
Accuracy of the 15.5-Day G7 iCGM in Adults with Diabetes
Diabetes Technology & Therapeutics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 20, 2025
Background:
Continuous
glucose
monitors
(CGM)
are
increasingly
being
used
to
manage
diabetes.
We
evaluated
the
performance
and
safety
of
an
investigational
15-day
G7
integrated
CGM
(iCGM;
Dexcom)
in
adults
with
Methods:
This
prospective,
multicenter
study
enrolled
(age
≥18
years)
type
1
diabetes
(T1D)
or
2
(T2D)
at
six
clinical
sites
United
States.
Four
in-clinic
visits
were
conducted
on
days
1-3,
4-7,
9-12,
13-15.5,
frequent
arterialized
venous
blood
draws
for
comparator
measurements
using
a
Yellow
Springs
Instrument
(YSI)
2300
Stat
Plus
analyzer.
Participants
T1D
T2D
intensive
insulin
therapy
participated
clinic
sessions
deliberate,
closely
monitored
manipulations.
Accuracy
evaluations
included
mean
absolute
relative
difference
(MARD),
proportion
values
within
15
mg/dL
YSI
<70
15%
≥70
(%15/15),
as
well
%20/20,
%30/30,
%40/40
agreement
rates.
Performance
related
iCGM
special
controls,
user
experience,
device
also
assessed.
Results:
The
130
(mean
±
standard
deviation
age
43.0
14.4
years,
53.1%
female,
86.9%
T1D)
analyzed
20,310
CGM-YSI
matched
pairs
from
devices.
overall
MARD
was
8.0%
%15/15,
rates
87.7%,
94.2%,
98.9%,
99.8%,
respectively.
exceeded
goals,
experiences
broadly
positive.
No
serious
adverse
events
reported.
Conclusions:
accurate
safe
throughout
15.5-day
wear
period.
Clinicaltrials.gov:
NCT05263258.
Language: Английский
Is the Impact of Sodium–Glucose Co-Transporter 2 (SGLT2) Inhibitors on Bone Metabolism and Fracture Incidence a Class or Drug Effect? A Narrative Review
Medicines,
Journal Year:
2025,
Volume and Issue:
12(2), P. 10 - 10
Published: April 16, 2025
Background/Objectives:
Type
2
diabetes
mellitus
(T2DM)
has
a
growing
prevalence,
even
in
developed
countries.
Because
of
the
increase
life
expectancy,
number
older
people
with
T2DM
is
also
increasing.
The
management
and
handling
these
patients
challenging
due
to
its
co-morbidities.
Aim:
In
present
study,
we
reviewed
literature
order
investigate
impact
sodium–glucose
co-transporter
inhibitors
(SGLT-2
inhibitors)
on
bone
metabolism
fracture
incidence.
Methods:
We
searched
using
databases
PubMed,
CENTRAL
Cochrane
Central
Register
Controlled
Trials
up
December
2024.
Results:
There
controversial
position
concerning
effects
SGLT2
when
administered
T2DM,
respect
Multiple
studies
suggest
have
disadvantageous
effect
incidence,
while
several
others
beneficial
effect.
Conclusions:
Patients
type
are
at
high
risk
alterations
their
metabolism.
novel
class
pleiotropic
many
organs,
such
as
kidneys
heart,
although
incidence
still
unclear.
Until
more
clinical
data,
all
caregivers
(medical
nursing
staff)
should
be
aware
possible
fractures
receiving
this
agents.
Language: Английский
Inpatient Management of Hyperglycemia
Jill K. Wagoner,
No information about this author
Palak Choksi
No information about this author
Oxford University Press eBooks,
Journal Year:
2025,
Volume and Issue:
unknown, P. 551 - 556
Published: April 1, 2025
Abstract
This
chapter
guides
the
reader
on
general
principles,
clinical
manifestations,
and
management
of
hyperglycemia
in
hospitalized
patients.
Language: Английский
How to take action beyond ambulatory glucose profile: Latin American expert recommendations on CGM data interpretation
Diabetology & Metabolic Syndrome,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: May 8, 2025
Abstract
Purpose
This
expert
consensus
provides
a
standardized
methodology
for
interpreting
continuous
glucose
monitoring
(CGM)
data
to
optimize
diabetes
management.
It
aims
help
healthcare
professionals
recognize
glycemic
patterns
and
apply
targeted
interventions
based
on
real-time
metrics.
Methods
A
systematic
literature
review
informed
panel
discussions.
Specialists
from
Latin
America
assessed
CGM
interpretation
challenges,
reviewed
key
metrics,
reached
through
an
anonymous
voting
process.
The
recommendations
align
with
international
guidelines
while
addressing
regional
limitations
in
technology
access
infrastructure.
Results
Reliable
requires
at
least
70%
sensor
use
over
14
days.
Ambulatory
Glucose
Profile
(AGP)
report
serves
as
the
primary
tool,
offering
essential
metrics
such
time
range
(TIR),
below
(TBR),
above
(TAR),
coefficient
of
variation
(CV),
management
indicator
(GMI).
Identifying
hyperglycemia,
hypoglycemia,
variability
allows
personalized
treatment
adjustments.
adopted
targets,
adapting
them
American
settings.
tight
(TITR)
was
considered
but
not
included
due
limited
supporting
evidence
barriers
advanced
technology.
Conclusions
Standardized
improves
control
decisions.
These
provide
structured
approach
care,
aiming
enhance
clinical
outcomes
address
disparities
America.
Language: Английский
Using Healthcare Claims Data to Identify Health Disparities for Individuals with Familial Hypercholesterolemia
Journal of clinical lipidology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 1, 2025
Language: Английский
Recomendaciones preventivas vasculares. Actualización PAPPS 2024
Atención Primaria,
Journal Year:
2024,
Volume and Issue:
56, P. 103123 - 103123
Published: Nov. 1, 2024
The
recommendations
of
the
semFYC's
Program
for
Preventive
Activities
and
Health
Promotion
(PAPPS)
prevention
vascular
diseases
(VD)
are
presented.
New
in
this
edition
new
sections
such
as
obesity,
chronic
kidney
disease
metabolic
hepatic
steatosis,
well
a
'Don't
Do'
section
different
pathologies
treated.
have
been
updated:
epidemiological
review,
where
current
morbidity
mortality
CVD
Spain
its
evolution
main
risk
factors
described;
(VR)
calculation
CV
risk;
arterial
hypertension,
dyslipidemia
diabetes
mellitus,
describing
method
their
diagnosis,
therapeutic
objectives
lifestyle
measures
pharmacological
treatment;
indications
antiplatelet
therapy,
screening
atrial
fibrillation,
management
conditions.
quality
testing
strength
recommendation
included
recommendations.
Language: Английский
A retrospective cohort study of a community-based primary care program’s effects on pharmacotherapy quality in low-income Peruvians with type 2 diabetes and hypertension
PLOS Global Public Health,
Journal Year:
2024,
Volume and Issue:
4(8), P. e0003512 - e0003512
Published: Aug. 22, 2024
Little
is
known
about
the
effects
of
Chronic
Care
Model
(CCM)
and
community
health
workers
(CHWs)
on
pharmacotherapy
type
2
diabetes
hypertension
in
resource-poor
settings.
This
retrospective
cohort
implementation
study
evaluated
a
community-based
program
consisting
CCM,
CHWs,
guidelines-based
treatment
protocols,
inexpensive
freely
accessible
medications
quality.
A
door-to-door
household
survey
identified
856
adults
35
years
age
older
living
low-income
Peruvian
community,
whom
83%
participated
screening
for
hypertension.
Patients
with
confirmed
and/or
program’s
weekly
to
monthly
visits
<
=
27
months.
The
was
implemented
as
two
care
periods
employed
sequentially.
During
home
care,
CHWs
made
physician
decisions
remotely.
subsequent
clinic
attended
patients
centralized
clinic.
compared
(pre-
versus
post-)
(N
262
observations),
211
observations)
standards
hypoglycemic
antihypertensive
agents,
angiotensin
converting
enzyme
inhibitors,
low-dose
aspirin.
program,
80%
50%
achieved
standards,
respectively,
35%
8%
prior
RRs
2.29
(1.72–3.04,
p
<0.001)
6.64
(3.17–13.9,
p<0.001).
Achievement
not
improved
by
(RRs
1.0
+/-
0.08).
In
both
periods,
longer
retention
(>50%
allowable
time)
associated
achievement
all
standards.
85%
56%
standard
shorter
retention,
RR
1.52
(1.13–2.06,
p<0.001);
27%
standard,
2.11
(1.29–3.45,
dose-dependent
manner,
Language: Английский
None
Izzatul Mardiah Saini,
No information about this author
Fatima Nur Misana,
No information about this author
Nurzahara Bagus
No information about this author
et al.
Jurnal Informasi Kesehatan Indonesia (JIKI),
Journal Year:
2023,
Volume and Issue:
9(1), P. 70 - 70
Published: May 26, 2023
Latar
Belakang:
Penyakit
tidak
menular
telah
menjadi
penyebab
utama
kematian
di
Indonesia.
Untuk
menanggulanginya,
pemerintah
Republik
Indonesia
membuat
beberapa
kebijakan
yang
menghasilkan
program
seperti
Pandu
PTM.
PANDU
PTM
merupakan
suatu
pendekatan
faktor
risiko
untuk
deteksi
dini
dan
pemantauan
terintegrasi
dilaksanakan
melalui
kegiatan
Posbindu
Tujuan
Penelitian:
Penelitian
ini
bertujuan
mengetahui
hubungan
antara
pelaksanaan
dengan
angka
kejadian
diabetes
melitus
Subjek
Metode:
dilakukan
dari
Maret-April
2023.
menggunakan
desain
observasional
analitik
studi
ekologi.
Sampel
dalam
penelitian
adalah
provinsi
berjumlah
34
Provinsi.
Data
digunakan
data
sekunder
diperoleh
Riskesdas
Tahun
2018
Profil
Kesehatan
2018.
Variabel
independen
persentase
capaian
variabel
dependen
prevalensi
melitus.
dianalisis
regresi
linier
sederhana
Hasil:
Hasil
menunjukkan
bahwa
ada
(Sig
=
0,191)
Kesimpulan:
Pelaksanaan
didukung
adanya
tenaga
kesehatan
ahli
masih
kurangnya
kesadaran
masyarakat.
Disarankan
meningkatkan
keahlian
petugas
masyarakat
akan
pentingnya
melaksanakan
resiko
penyakit.